OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Application of Organoid Models in Prostate Cancer Research
Ligui Zhou, Caiqin Zhang, Yongbin Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14

Showing 14 citing articles:

Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications
Sushila Maharjan, Chenshuo Ma, Bibhor Singh, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115237-115237
Closed Access | Times Cited: 30

Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
S.Y. Jeong, Minyong Kang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14609-14609
Open Access | Times Cited: 22

Organoids: opportunities and challenges of cancer therapy
Xianjie Jiang, Linda Oyang, Peng Qiu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 19

Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research
Mohammad Waseem, Bi‐Dar Wang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1093-1093
Open Access | Times Cited: 8

Advances in the application of 3D tumor models in precision oncology and drug screening
Xiaoyong Guan, Shigao Huang
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 21

Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers
Whi‐An Kwon, Jae Young Joung
Biomolecules (2025) Vol. 15, Iss. 5, pp. 625-625
Open Access

Prostate Cancer: Emerging Modifiable Risk Factors and Therapeutic Strategies in the Management of Advanced Cancer
Sabrina Bossio, Lidia Urlandini, Anna Perri, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1094-1094
Open Access | Times Cited: 2

Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer
Chandra Kishore, Xiaolin Zi
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 261-274
Open Access | Times Cited: 5

New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
Vittoria Rago, Anna Perri, Silvia Di Agostino
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2743-2743
Open Access | Times Cited: 4

Defining the challenges and opportunities for using patient‐derived models in prostate cancer research
W. Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
The Prostate (2024) Vol. 84, Iss. 7, pp. 623-635
Open Access | Times Cited: 1

Current status and clinical application of patient-derived tumor organoid model in kidney and prostate cancers
Eunjeong Seo, Minyong Kang
BMB Reports (2022) Vol. 56, Iss. 1, pp. 24-31
Open Access | Times Cited: 3

Applications of Tumor Cells in an In Vitro 3D Environment
Sylwia Hasterok, Anna Gustafsson, Anette Gjörloff Wingren
Applied Sciences (2023) Vol. 13, Iss. 18, pp. 10349-10349
Open Access | Times Cited: 1

Developing a Novel Enzalutamide‐Resistant Prostate Cancer Model via AR F877L Mutation in LNCaP Cells
Ruifeng Wang, Shuhua Ma, Nengwei Xu, et al.
Current Protocols (2024) Vol. 4, Iss. 4
Closed Access

Early Cell Cultures from Prostate Cancer Tissue Express Tissue Specific Epithelial and Cancer Markers
Vladimir Ryabov, Mikhail M. Baryshev, M. A. Voskresenskiy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2830-2830
Open Access

Page 1

Scroll to top